Acute secondhand Smoke-Induced pulmonary inflammation is diminished in RAGE knockout mice

American Journal of Physiology - Lung Cellular and Molecular Physiology

Volumn 307, Issue 10, 2014, Pages L758-L764

  Wood, Tyler T ^a   Winden, Duane R ^a   Marlor, Derek R ^a   Wright, Alex J ^a   Jones, Cameron M ^a   Chavarria, Michael ^a   Rogers, Geraldine D ^a   Reynolds, Paul R ^a  

^a BRIGHAM YOUNG UNIVERSITY   (United States)

Author keywords

Inflammation; Lung; RAGE; Secondhand smoke

Indexed keywords

ADVANCED GLYCATION END PRODUCT RECEPTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 8; TUMOR NECROSIS FACTOR ALPHA; ADVANCED GLYCOSYLATION END-PRODUCT RECEPTOR; IMMUNOGLOBULIN RECEPTOR; PASSIVE SMOKING; RAS PROTEIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; HISTOPATHOLOGY; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; INFLAMMATORY CELL; KNOCKOUT MOUSE; LEUKOCYTE; LUNG LAVAGE; MOUSE; NONHUMAN; PASSIVE SMOKING; PNEUMONIA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WILD TYPE; ACUTE DISEASE; ANIMAL; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PATHOLOGY; SIGNAL TRANSDUCTION;

ACUTE DISEASE; ANIMALS; GENE EXPRESSION REGULATION; MICE; MICE, KNOCKOUT; NF-KAPPA B; PNEUMONIA; RAS PROTEINS; RECEPTORS, IMMUNOLOGIC; SIGNAL TRANSDUCTION; TOBACCO SMOKE POLLUTION;

EID: 84925134033     PISSN: 10400605     EISSN: 15221504     Source Type: Journal    
DOI: 10.1152/ajplung.00185.2014     Document Type: Article

References (49)

1. Aufderheide M, Knebel JW, Ritter D. An improved in vitro model for testing the pulmonary toxicity of complex mixtures such as cigarette smoke. Exp Toxicol Pathol 55: 51-57, 2003.
2. Bozinovski S, Anthony D, Anderson GP, Irving LB, Levy BD, Vlahos R. Treating neutrophilic inflammation in COPD by targeting AXL/FPR2 resolution pathways. Pharmacol Ther 140: 280-289, 2013.
3. Buckley ST, Ehrhardt C. The receptor for advanced glycation endproducts (RAGE) and the lung. J Biomed Biotechnol 2010: 917108, 2010.
4. Caramori G, Adcock IM, Di Stefano A, Chung KF. Cytokine inhibition in the treatment of COPD. Int J Chron Obstruct Pulmon Dis 9: 397-412, 2014.
5. Chen L, Liu L, Wang T, Shen YC, Wen FQ. Receptor for advanced glycation end products: a new theraputic target for chronic obstructive pulmonary disease? Arch Med Res 44: 75-76, 2013.
6. Chung KF. Inflammatory mediators in chronic obstructive pulmonary disease. Curr Drug Targets Inflamm Allergy 4: 619-625, 2005.
7. Chung MK, Lee SJ, Kim MY, Lee JH, Chang JH, Sim SS, Ryu YJ. Acute eosinophilic pneumonia following secondhand cigarette smoke exposure. Tuberc Respir Dis (Seoul) 76: 188-191, 2014.
8. Demling N, Ehrhardt C, Kasper M, Laue M, Knels L, Rieber EP. Promotion of cell adherence and spreading: a novel function of RAGE, the highly selective differentiation marker of human alveolar epithelial type I cells. Cell Tissue Res 14: 475-488, 2006.
9. Driscoll KE. Macrophage inflammatory proteins: biology and role in pulmonary inflammation. Exp Lung Res 20: 473-490, 1994.
10. Englert JM, Hanford LE, Kaminski N, Tobolewski JM, Tan RJ, Fattman CL, Ramsgaard L, Richards TJ, Loutaev I, Nawroth PP, Kasper M, Bierhaus A, Oury TD. A role for the receptor for advanced glycation end products in idiopathic pulmonary fibrosis. Am J Pathol 14: 583-591, 2008.
11. Fritz G. RAGE: a single receptor fits multiple ligands. Trends Biochem Sci 36: 625-632, 2011.
12. Kyan-Aung U, Haskard DO, Poston RN, Thornhill MH, Lee TH. Endothelial leukocyte adhesion molecule-1 and intercellular adhesion molecule-1 mediate the adhesion of eosinophils to endothelial cells in vitro and are expressed by endothelium in allergic cutaneous inflammation in vivo. J Immunol 146: 521-528, 1991.
13. Laskin DL. Macrophages and inflammatory mediators in chemical toxicity: a battle of forces. Chem Res Toxicol 22: 1376-1385, 2009.
14. Laskin DL, Sunil VR, Fakhrzadeh L, Groves A, Gow AJ, Laskin JD. Macrophages, reactive nitrogen species, and lung injury. Ann NY Acad Sci 1203: 60-65, 2010.
15. Leberl M, Kratzer A, Taraseviciene-Stewart L. Tobacco smoke induced COPD/emphysema in the animal model-are we all on the same page? Front Physiol 4: 91, 2013.
16. MacNee W. Pathogenesis of chronic obstructive pulmonary disease. Proc Am Thorac Soc 2: 258-266, 2005.
17. McCrea KA, Ensor JE, Nall K, Bleecker ER, Hasday JD. Altered cytokine regulation in the lungs of cigarette smokers. Am J Respir Crit Care Med 150: 696-703, 1994.
18. Miniño A. Mortality among teenagers aged 12-19 years: United States, 1999-2006. NCHS Data Brief 37: 1-8, 2010.
19. Moussa SB, Sfaxi I, Tabka Z, Ben Saad H, Rouatbi S. Oxidative stress and lung function profiles of male smokers free from COPD compared to those with COPD: a case-control study. Libyan J Med 9: 23873, 2014.
20. Nicholl ID, Stitt AW, Moore JE, Ritchie AJ, Archer DB, Bucala R. Increased levels of advanced glycation endproducts in the lenses and blood vessels of cigarette smokers. Mol Med 4: 594-601, 1998.
21. Nicholl ID, Bucala R. Advanced glycation endproducts and cigarette smoking. Cell Mol Biol (Noisy-le-grand) 44: 1025-1033, 1998.
22. Okuwa K, Tanaka M, Fukano Y, Nara H, Nishijima Y, Nishino T. In vitro micronucleus assay for cigarette smoke using a whole smoke exposure system: a comparison of smoking regimens. Exp Toxicol Pathol 62: 433-440, 2010.
23. Pauwels RA, Buist AS, Ma P, Jenkins CR, Hurd SS. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: national heart, lung, and blood institute and world health organization global initiative for chronic obstructive lung disease (GOLD): executive summary. Respir Care 46: 798-825, 2001.
24. Phillips J, Kluss B, Richter A, Massey E. Exposure of bronchial epithelial cells to whole cigarette smoke: assessment of cellular responses. Altern Lab Anim 33: 239-248, 2005.
25. Reynolds PR, Mucenski ML, Le Cras TD, Nichols WC, Whitsett JA. Midkine is regulated by hypoxia and causes pulmonary vascular remodeling. J Biol Chem 279: 37124-37132, 2004.
26. Reynolds PR, Schmitt RE, Kasteler SD, Sturrock A, Sanders K, Bierhaus A, Nawroth PP, Paine R 3rd, Hoidal JR. Receptors for advanced glycation end-products targeting protect against hyperoxiainduced lung injury in mice. Am J Respir Cell Mol Biol 42: 545-551, 2010.
27. Reynolds PR, Kasteler SD, Schmitt RE, Hoidal JR. Receptor for advanced glycation end-products signals through Ras during tobacco smoke-induced pulmonary inflammation. Am J Respir Cell Mol Biol 45: 411-418, 2010.
28. Reynolds PR, Stogsdill JA, Stogsdill MP, Heimann NB. Up-regulation of receptors for advanced glycation end-products by alveolar epithelium influences cytodifferentiation and causes severe lung hypoplasia. Am J Respir Cell Mol Biol 45: 1195-1202, 2011.
29. Reynolds PR, Cosio MG, Hoidal JR. Cigarette smoke-induced Egr-1 upregulates proinflammatory cytokines in pulmonary epithelial cells. Am J Respir Cell Mol Biol 35: 314, 2006.
30. Reynolds PR, Kasteler SD, Cosio MG, Sturrock A, Huecksteadt T, Hoidal JR. RAGE: developmental expression and positive feedback regulation by Egr-1 during cigarette smoke exposure in pulmonary epithelial cells. Am J Physiol Lung Cell Mol Physiol 294: L1094-L1101, 2008.
31. Rinaldi M, Maes K, De Vleeschauwer S, Thomas D, Verbeken EK, Decramer M, Janssens W, Gayan-Ramirez GN. Long-term nose-only cigarette smoke exposure induces emphysema and mild skeletal muscle dysfunction in mice. Dis Model Mech 5: 333-341, 2012.
32. Robinson AB, Johnson KD, Bennion BG, Reynolds PR. RAGE signaling by alveolar macrophages influences tobacco smoke-induced inflammation. Am J Physiol Lung Cell Mol Physiol 302: L1192-L1199, 2012.
33. Robinson AB, Stogsdill JA, Lewis JB, Wood TT, Reynolds PR. RAGE and tobacco smoke: insights into modeling chronic obstructive pulmonary disease. Front Physiol 3: 301, 2012.
34. Scian MJ, Oldham MJ, Kane DB, Edmiston JS, McKinney WJ. Characterization of a whole smoke in vitro exposure system (Burghart Mimic Smoker-01). Inhal Toxicol 21: 234-243, 2009.
35. Sims GP, Rowe DC, Rietdijk ST, Herbst R, Coyle AJ. HMGB1 and RAGE in inflammation and cancer. Annu Rev Immunol 28: 367-388, 2010.
36. Sparvero LJ, Asafu-Adjei D, Kang R, Tang D, Amin N, Im J, Rutledge R, Lin B, Amoscato AA, Zeh HJ, Lotze MT. RAGE (Receptor for Advanced Glycation Endproducts), RAGE ligands, and their role in cancer and inflammation. J Transl Med 7: 17, 2009.
37. Stockley RA. Neutrophils and the pathogenesis of COPD. Chest 121: 151S-155S, 2002.
38. Stogsdill JA, Stogsdill MP, Porter JL, Hancock JM, Robinson AB, Reynolds PR. Embryonic over-expression of RAGE by alveolar epithe- lium induces an imbalance between proliferation and apoptosis. Am J Respir Cell Mol Biol 14: 60-66, 2012.
39. Stogsdill MP, Stogsdill JA, Bodine BG, Fredrickson AC, Sefcik TL, Wood TA, Kasteler SK, Reynolds PR. Conditional RAGE over expression in the adult murine lung causes airspace enlargement and induces inflammation. Am J Respir Cell Mol Biol 49: 128-134, 2013.
40. Thornally PJ. Cell activation by glycated proteins. AGE receptors, receptor recognition factors and functional classification of AGEs. Cell Mol Biol (Noisy-Le-Grand) 44: 1013-1023, 1998.
41. Thorne D, Kilford J, Payne R, Haswell L, Dalrymple A, Meredith C, Dillon D. Development of a BALB/c 3T3 neutral red uptake cytotoxicity test using a mainstream cigarette smoke exposure system. BMC Res Notes 7: 367, 2014.
42. Vijayan VK. Chronic obstructive pulmonary disease (Review). Indian J Med Res 137: 251-269, 2013.
43. Vlahos R, Bozinovski S, Chan SP, Ivanov S, Linden A, Hamilton JA, Anderson GP. Neutralizing granulocyte/macrophage colony-stimulating factor inhibits cigarette smoke-induced lung inflammation. Am J Respir Crit Care Med 182: 34-40, 2010.
44. Wendt TM, Tanji N, Guo J, Kislinger TR, Qu W, Lu Y, Bucciarelli LG, Rong LL, Moser B, Markowitz GS, Stein G, Bierhaus A, Liliensiek B, Arnold B, Nawroth PP, Stern DM, D'Agati VD, Schmidt AM. RAGE drives the development of glomerulosclerosis and implicates podocyte activation in the pathogenesis of diabetic nephropathy. Am J Pathol 162: 1123-1137, 2003.
45. Wesselborg S, Bauer MKA, Vogt M, Schmitz ML, Schulze-Osthoff K. Activation of transcription factor NF-κB and p38 mitogen-activated protein kinase is mediated by distinct and separate stress effector pathways. J Biol Chem 272: 12422-12429, 1997.
46. Winden DR, Ferguson NT, Bukey BR, Geyer AJ, Wright AJ, Jergensen ZR, Robinson AB, Stogsdill JA, Reynolds PR. Conditional over-expression of RAGE by embryonic alveolar epithelium compromises the respiratory membrane and impairs endothelial cell differentiation. Respir Res 14: 108, 2013.
47. Wright JL, Cosio M, Churg A. Animal models of chronic obstructive pulmonary disease. Am J Physiol Lung Cell Mol Physiol 295: L1-L15, 2008.
48. Wu L, Ma L, Nicholson LFB, Black PN. Advanced glycation end products and its receptor (RAGE) are increased in patients with COPD. Respir Med 105: 329-336, 2011.
49. Yi L, Chen W, Tsai WK, Lee JC, Chiou HL, Shih CM, Wang YC. Polymorphisms of p53 and p21 genes in chronic obstructive pulmonary disease. J Lab Clin Med 147: 228-233, 2006.